ArticleFrontiers in immunology2022

Clinical Significance of Novel Neutrophil-Based Biomarkers in the Diagnosis and Prediction of Response to Infliximab Therapy in Crohn's Disease.

Zhou Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.